WeChat Mini Program
Old Version Features

Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial

Bronwen E. Shaw,Antonio Martin Jimenez-Jimenez,Linda J. Burns,Brent R. Logan,Farhad Khimani,Brian C. Shaffer,Nirav N. Shah,Alisha Mussetter,Xiao-Ying Tang,John M. McCarty,Asif Alavi,Nosha Farhadfar,Katarzyna Jamieson,Nancy M. Hardy,Hannah Choe,Richard F. Ambinder,Claudio Anasetti,Miguel -Angel Perales,Stephen R. Spellman,Alan Howard,Krishna V. Komanduri,Leo Luznik,Maxim Norkin,Joseph A. Pidala,Voravit Ratanantharathorn,Dennis L. Confer,Steven M. Devine,Mary M. Horowitz,Javier Bolanos-Meade

TRANSPLANTATION AND CELLULAR THERAPY（2023）

Cited 23|Views42
Key words
Mismatched unrelated donor,Post transplant cyclophosphamide,Hematopoietic cell transplant,HLA
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined